Better Risk-Tolerant Investors: Hyperliquid or XRP—A Guide
For investors who can stomach big swings, choosing between XRP and Hyperliquid isn’t simple. This guide breaks down r...
Find out when rewards points are truly worth it. Maximize your benefits and learn how to save more on your travels.
15,541 articlesFor investors who can stomach big swings, choosing between XRP and Hyperliquid isn’t simple. This guide breaks down r...
Apple signals a strategic pivot, moving its flagship away from the iPhone toward ambient computing with Vision Pro an...
GameStop’s bid to acquire eBay is stirring a heated market debate over value and risk. Analysts say the move may be m...
XRP-linked ETFs are drawing persistent institutional inflows even as XRP trades in a tight $1.40-$1.47 range. A fresh...
A major hedge fund just plowed a substantial stake into a gene-editing company, signaling conviction in Beam Therapeu...
Syndicate Labs, a16z-backed, is closing its development arm after five years of building on-chain tooling, blaming a ...
Midweek market noise is loud. This Wednesday reads roundup cuts through the chatter with 10 practical investing stori...
The Pentagon says commercial data was used to target U.S. service members, a development that could spur tighter data...
Bristol Myers Squibb stock often appears attractively priced, with a solid dividend. But when you look under the hood...
Eli Lilly’s GLP-1 drugs are redefining growth in obesity and diabetes treatment. This article lays out why the stock ...
Emerging markets are outpacing the S&P 500 in 2026, with EEM posting a double-digit lead year-to-date. The rally cent...
Lemonade is doubling down on artificial intelligence to reshape insurance. This piece breaks down what lemonade betti...